Cargando…
Stroke in Middle Eastern children with cancer: prevalence and risk factors
OBJECTIVE: To determine the prevalence and to characterize the different types of strokes in children with cancer at the Children’s Cancer Center of Lebanon (CCCL), in addition to assess the factors and clinical findings leading to stroke in children. METHODS: We retrospectively reviewed the medical...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8764852/ https://www.ncbi.nlm.nih.gov/pubmed/35042459 http://dx.doi.org/10.1186/s12883-022-02556-x |
_version_ | 1784634247427915776 |
---|---|
author | Zadeh, Catherina AlArab, Natally Muwakkit, Samar Atweh, Lamya A. Tamim, Hani Makki, Maha Salhab, Hamza A. Hourani, Roula |
author_facet | Zadeh, Catherina AlArab, Natally Muwakkit, Samar Atweh, Lamya A. Tamim, Hani Makki, Maha Salhab, Hamza A. Hourani, Roula |
author_sort | Zadeh, Catherina |
collection | PubMed |
description | OBJECTIVE: To determine the prevalence and to characterize the different types of strokes in children with cancer at the Children’s Cancer Center of Lebanon (CCCL), in addition to assess the factors and clinical findings leading to stroke in children. METHODS: We retrospectively reviewed the medical records and brain images (MRIs and CTs) of children admitted to the CCCL and diagnosed with cancer between years 2008 and 2017. Brain images were reviewed for the strokes’ onset, size, location, possible origin, its recurrence and type: intracranial hemorrhage (ICH), acute arterial ischemic stroke, and cerebral sinus venous thrombosis (CSVT) with and without venous infarct. Medical charts of the patients were reviewed for age, sex, their type of cancer, the treatment protocol they followed, and abnormal findings on their laboratory studies and neurological exams. RESULTS: Out of the 905 charts reviewed, twenty-seven children with variable types of cancer had strokes, with a prevalence of 2.9%. Their median age at cancer diagnosis was 9.4 (4.8-13.7) years and the median age at stroke onset was 10.6 (6.7-15.5) years. The median time between the cancer diagnosis and the stroke episode was 6 months. CSVT cases were the most common (60%) followed by acute arterial ischemic (22%) and hemorrhagic strokes (18%), with CSVT being the latest to occur. We observed that the different types of strokes were related to some types of cancer. Of the children that had acute arterial ischemic stroke in this cohort, 83% had brain tumors, of the children who had CSVT, 87.5% had leukemia, and of the children who had hemorrhagic stroke, 40% had leukemia. Neurological abnormalities were more prevalent in acute arterial ischemic stroke (80%). Patients with CSVT recovered better than those with other types of strokes. Strokes recurred in 60% of ischemic strokes. L-Asparaginase was significantly associated with CSVT. CONCLUSIONS: The prevalence of strokes was 2.9% in children with cancer. We were able to identify factors related to the types of the stroke that occurred in children including the type and location of the cancer the type of treatment received, and stroke recurrence. |
format | Online Article Text |
id | pubmed-8764852 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-87648522022-01-19 Stroke in Middle Eastern children with cancer: prevalence and risk factors Zadeh, Catherina AlArab, Natally Muwakkit, Samar Atweh, Lamya A. Tamim, Hani Makki, Maha Salhab, Hamza A. Hourani, Roula BMC Neurol Research OBJECTIVE: To determine the prevalence and to characterize the different types of strokes in children with cancer at the Children’s Cancer Center of Lebanon (CCCL), in addition to assess the factors and clinical findings leading to stroke in children. METHODS: We retrospectively reviewed the medical records and brain images (MRIs and CTs) of children admitted to the CCCL and diagnosed with cancer between years 2008 and 2017. Brain images were reviewed for the strokes’ onset, size, location, possible origin, its recurrence and type: intracranial hemorrhage (ICH), acute arterial ischemic stroke, and cerebral sinus venous thrombosis (CSVT) with and without venous infarct. Medical charts of the patients were reviewed for age, sex, their type of cancer, the treatment protocol they followed, and abnormal findings on their laboratory studies and neurological exams. RESULTS: Out of the 905 charts reviewed, twenty-seven children with variable types of cancer had strokes, with a prevalence of 2.9%. Their median age at cancer diagnosis was 9.4 (4.8-13.7) years and the median age at stroke onset was 10.6 (6.7-15.5) years. The median time between the cancer diagnosis and the stroke episode was 6 months. CSVT cases were the most common (60%) followed by acute arterial ischemic (22%) and hemorrhagic strokes (18%), with CSVT being the latest to occur. We observed that the different types of strokes were related to some types of cancer. Of the children that had acute arterial ischemic stroke in this cohort, 83% had brain tumors, of the children who had CSVT, 87.5% had leukemia, and of the children who had hemorrhagic stroke, 40% had leukemia. Neurological abnormalities were more prevalent in acute arterial ischemic stroke (80%). Patients with CSVT recovered better than those with other types of strokes. Strokes recurred in 60% of ischemic strokes. L-Asparaginase was significantly associated with CSVT. CONCLUSIONS: The prevalence of strokes was 2.9% in children with cancer. We were able to identify factors related to the types of the stroke that occurred in children including the type and location of the cancer the type of treatment received, and stroke recurrence. BioMed Central 2022-01-18 /pmc/articles/PMC8764852/ /pubmed/35042459 http://dx.doi.org/10.1186/s12883-022-02556-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Zadeh, Catherina AlArab, Natally Muwakkit, Samar Atweh, Lamya A. Tamim, Hani Makki, Maha Salhab, Hamza A. Hourani, Roula Stroke in Middle Eastern children with cancer: prevalence and risk factors |
title | Stroke in Middle Eastern children with cancer: prevalence and risk factors |
title_full | Stroke in Middle Eastern children with cancer: prevalence and risk factors |
title_fullStr | Stroke in Middle Eastern children with cancer: prevalence and risk factors |
title_full_unstemmed | Stroke in Middle Eastern children with cancer: prevalence and risk factors |
title_short | Stroke in Middle Eastern children with cancer: prevalence and risk factors |
title_sort | stroke in middle eastern children with cancer: prevalence and risk factors |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8764852/ https://www.ncbi.nlm.nih.gov/pubmed/35042459 http://dx.doi.org/10.1186/s12883-022-02556-x |
work_keys_str_mv | AT zadehcatherina strokeinmiddleeasternchildrenwithcancerprevalenceandriskfactors AT alarabnatally strokeinmiddleeasternchildrenwithcancerprevalenceandriskfactors AT muwakkitsamar strokeinmiddleeasternchildrenwithcancerprevalenceandriskfactors AT atwehlamyaa strokeinmiddleeasternchildrenwithcancerprevalenceandriskfactors AT tamimhani strokeinmiddleeasternchildrenwithcancerprevalenceandriskfactors AT makkimaha strokeinmiddleeasternchildrenwithcancerprevalenceandriskfactors AT salhabhamzaa strokeinmiddleeasternchildrenwithcancerprevalenceandriskfactors AT houraniroula strokeinmiddleeasternchildrenwithcancerprevalenceandriskfactors |